Top Swiss court rules that recommended retail prices are anticompetitive
Switzerland’s highest court has ruled that Pfizer’s recommended price-lists for an erectile dysfunction drug restricted competition, in a decision that local competition lawyers say creates uncertainty about the legality of recommended resale prices.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.